# N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers

> **NCT00967005** · PHASE2 · COMPLETED · sponsor: **University of Chicago** · enrollment: 28 (actual)

## Conditions studied

- Gambling
- Tobacco Use Disorder

## Interventions

- **DRUG:** N Acetyl Cysteine
- **OTHER:** Sugar Pill

## Key facts

- **NCT ID:** NCT00967005
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-09
- **Final completion:** 2014-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2023-03-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00967005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00967005, "N-Acetyl Cysteine Plus Behavioral Therapy for Nicotine Dependent Pathological Gamblers". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT00967005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*